Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Innovator companies are not required to publish their patent lists proactively at the time of biologics license application (BLA) approval
Every treatment plan is personalized based on a child's medical history, metabolic health, growth, and long-term goals
Comparison is for context from published records
Frequency Considerations BPC-157 has a relatively short half-life of less than 30 minutes, which raises questions about optimal dosing frequency
US$ 23.66
US$ 25.05
US$ 24.51
US$ 25.58
US$ 20.45
US$ 27.75
US$ 20.23
US$ 28.72
US$ 26.83
US$ 24.72
US$ 21.85
US$ 29.08
US$ 22.90
US$ 28.15
US$ 27.76
